SP-002(Simcere)

N/A

Report date: 2023/04/24 17:35:22
NME

Base Information

Drug NameSP-002(Simcere)
Drug Alias NameSP-002(Simcere)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUbiquitin carboxyl-terminal hydrolase 1 inhibitors
TargetsUbiquitin carboxyl-terminal hydrolase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangsu Simcere Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Simcere Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A